Investigación / Grupos de investigación

Grupo  2

Fisiopatología e Historia Natural de las Enfermedades Hepáticas y Gastroenterológicas

Publicaciones (549)

  • Alvarado-Tapias E; Pose E; Gratacós-Ginès J; Clemente-Sánchez A; López-Pelayo H; Bataller R.

    Alcohol-associated liver disease: Natural history, management and novel targeted therapies.

    Clinical and molecular hepatology. 2025; 31(Suppl): Nº de citas: 4 [doi:10.3350/cmh.2024.0709]

  • Tejerina, F; Peñas-Utrilla, D; Herranz, M; Catalán, P; Marín, M; Mesones, L; García-Domínguez, JM; Merino, B; Pérez, L; Fanciulli, C; Muñoz, P; Rodríguez-Gonzalez, C; Diez, C; Aldámiz, T; Molero-Salinas, A; Pérez-Lago, L; de Viedma, DG.

    Chronic Systemic SARS-CoV-2 Infection Without Respiratory Involvement in an Immunocompromised Patient

    Viruses-Basel. 2025; 17(2): [doi:10.3390/v17020147]

  • Mesonero, F; Zabana, Y; Fernández-Clotet, A; Solá, A; Caballol, B; Leo-Carnerero, E; García, MJ; Bertoletti, F; Bastida, G; Suris, G; Casis, B; Ferreiro-Iglesias, R; Calafat, M; Jiménez, I; Miranda-Bautista, J; Lamuela, LJ; Fajardo, I; Torrealba, L; Nájera, R; Sáiz-Chumillas, RM; González-Partida, I; Vicuña, M; García-Morales, N; Gutiérrez, A; López-García, A; Benitez, JM; de Célix, CR; Tejido, C; Brunet, E; Hernandez-Camba, A; Suárez, C; Rodríguez-Lago, I; Piqueras, M; Castaño, A; Ramos, L; Sobrino, A; Rodríguez-Grau, MC; Elosua, A; Montoro, M; Baltar, R; Huguet, JM; Hermida, B; Caballero-Mateos, A; Sánchez-Guillén, L; Bouhmidi, A; Pajares, R; Baston-Rey, I; López-Sanromán, A; Albillos, A; Barreiro-de Acosta, M.

    Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCU

    DIGESTIVE AND LIVER DISEASE. 2025; 57(2): 566-573 Nº de citas: 1 [doi:10.1016/j.dld.2024.09.023]

  • Sánchez-Aldehuelo, R; Villanueva, C; Genescà, J; García-Pagán, JC; Castillo, E; Calleja, JL; Aracil, C; Bañares, R; Téllez, L; Paule, L; Morillas, RM; Poca, M; Peñas, B; Augustin, S; Abraldes, JG; Alvarado-Tapias, E; Bosch, J; Albillos, A.

    Progressive systemic inflammation precedes decompensation in compensated cirrhosis

    Jhep Reports. 2025; 7(2): Nº de citas: 2 [doi:10.1016/j.jhepr.2024.101231]

  • Sarmiento, E; Ezzahouri, I; Jimenez-Lopez, M; Carré, KML; Alonso, R; Ortiz-Bautista, C; Plaza, MS; Rodríguez-Ferrero, ML; Padilla-Machaca, PM; Cerron, A; Chaman, JC; Salvo, APV; Carbone, J.

    A New Routine Immunity Score (RIS2020) to Predict Severe Infection in Solid-Organ Transplant Recipients

    ANNALS OF TRANSPLANTATION. 2025; 30: [doi:10.12659/AOT.946233]

  • Ukashi, O; Amiot, A; Laharie, D; Menchen, L; Gutierrez, A; Fernandes, S; Pessarelli, T; Correia, F; Gonzalez-Munoza, C; Lopez-Cardona, J; Calabrese, G; Ferreiro-Iglesias, R; Tamir-Degabli, N; Dussias, NK; Mousa, A; Oliveira, R; Richard, N; Veisman, I; Sharif, K; Ben-Horin, S; Soutullo-Castineiras, C; Dragoni, G; Rotulo, S; Favale, A; Calmejane, L; Bazin, T; Elosua, A; Lopes, S; Felice, C; Mauriz, V; Rodrigues, IC; Jougon, J; Botto, I; de Sousa, HT; Bertani, L; Abadia, PR; De Bernardi, A; Zabana, Y; Serra-Ruiz, X; Viola, A; Acosta, MBD; Yanai, H; Armuzzi, A; Magro, F; Kopylov, U.

    Inter-Rater Disagreements in Applying the Montreal Classification for Crohn's Disease: The Five-Nations Survey Study

    United European Gastroenterology Journal. 2025; 13(5): 685-696 [doi:10.1002/ueg2.12757]

  • Cerna, C; Vidal-Herrera, N; Silva-Olivares, F; Alvarez, D; Hidalgo, M; Aguirre, P; González-Urra, J; Astudillo-Guerrero, C; Jara, M; Porras, O; Cruz, G; Hodar, C; Llanos, P; Urrutia, P; Ibacache-Quiroga, C; Nevzorova, Y; Cubero, FJ; Fuenzalida, M; Thomas-Valdés, S; Jorquera, G.

    Fecal Microbiota Transplantation from Young-Trained Donors Improves Cognitive Function in Old Mice Through Modulation of the Gut-Brain Axis

    Aging and Disease. 2025; : Nº de citas: 2 [doi:10.14336/AD.2024.1089]

  • Mohamed, MR; Zhao, G; Volkert, I; Molinaro, A; Schneider, CV; Strnad, P; Hengstler, JG; Xu, C; Davis, RJ; Schneider, KM; Cubero, FJ; Trautwein, C.

    Differential Protective Roles of c-Jun N-terminal Kinase-2 in Nonparenchymal Liver Cells and Hepatocytes During Cholestasis

    CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY. 2025; 19(11): [doi:10.1016/j.jcmgh.2025.101588]

  • Rodríguez-Lago, I; Menchén, L; Sánchez-Hernández, JG; Guardiola, J; Merino-Bohórquez, V; Garcillán, B; Moreno-Cubero, E; Vispo, E; Domènech, E.

    Defining partial response in inflammatory bowel disease: a Delphi consensus and economic evaluation

    Therapeutic Advances in Gastroenterology. 2025; 18: [doi:10.1177/17562848251360907]

  • Alonso-Castellano, P; Mariño, Z; Tugores, A; Olveira, A; Ampuero, J; Berenguer, M; Fernández-Ramos, JR; Moreno-Planas, JM; Lázaro-Ríos, M; Masnou, H; González-Diéguez, ML; Pinazo-Bandera, JM; Molina-Pérez, E; Hernández-Guerra, M; Romero-Gutiérrez, M; Fernández-Alvarez, P; Muñoz, C; Lorente, S; Cachero, A; Delgado-Blanco, M; Vargas, V; Gómez-Camarero, J; Cuenca, F; Ibáñez-Samaniego, L; Fernández-Bermejo, M; Alvarez-Suárez, B; Iruzubieta, P; Arencibia-Almeida, A; García-Villarreal, L.

    Genetic map of Wilson disease in Spain-A great tool to improve diagnosis and screening

    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS. 2025; 117(5): 249-255 [doi:10.17235/reed.2025.11005/2024]

  • Rodríguez-Lago, I; Marigorta, UM; Mateos, B; Mañosa, M; Márquez-Mosquera, L; Menchén, L; Rodríguez-Moranta, F; Alonso, I; Aguas, M; Alonso-Galán, H; Borràs, P; Castro, B; Domenech, E; Ferreiro-Iglesias, R; de Francisco, R; García-Alonso, FJ; García, N; García-Bosch, O; Gargallo, C; Gisbert, JP; Iglesias, E; Mesonero, F; de Zárate, JO; Ramos, L; Sáinz, E; Ladrón, P; Suria, C; Ferrer, CS; Tejido, C; Varela, P; Vicente, R; Zabana, Y; Castany, G; Rodríguez, E; Gutierrez, A; Acosta, MBD.

    Natural history, immunological and genetic characteristics of preclinical inflammatory bowel disease (EARLY): study protocol for a prospective cohort study

    Therapeutic Advances in Gastroenterology. 2025; 18: Nº de citas: 1 [doi:10.1177/17562848251338647]

  • Marin-Jiménez, I; Aguirregabiria, I; Díaz-Cerezo, S; Moyano, S; Gabilondo, H; Knight, H; Harvey, N; Gibble, TH; Nos, P.

    Unmet needs in adult patients with ulcerative colitis in Spain: a real-world Adelphi Disease Specific Programme study

    Therapeutic Advances in Gastroenterology. 2025; 18: [doi:10.1177/17562848251325190]

  • Giordano A; Pérez-Martínez I; Gisbert JP; Ricart E; Martín-Arranz MD; Mesonero F; Parga MLC; Rivero M; Iglesias E; Fernández-Prada S; Calafat M; Villarino MTA; de Jorge Turrión MÁ; Hernández-Camba A; Lidón RV; Carpio D; Brunet E; Moranta FR; García LA; Cuquerella JT; Bermejo F; Madero L; Esteve M; González-Muñoza C; Martínez-Montiel P; Huguet JM; Pérez Calle JL; Rodríguez-Lago I; Ausín MS; Poyatos RHL; García-Bosch O; Marín GS; Taxonera C; Ponferrada-Diaz Á; Acosta MB; Bujanda L; Serra RB; Ramos L; Vera I; Abizanda ES; Piqueras M; Gómez CS; García-Sepulcre MF; Arregui MV; Murillo NR; Llaó J; Lucendo AJ; Marín-Jiménez I; Camps-Aler B; Villafranca CM; Ceballos D; Ver Y; Fernández-Salazar LI; Alcaín G; Valldosera G; Andrés PR; Martínez-Flores C; Coronel AF; Ginard D; García L; Gómez IB; Argüelles-Arias F; Miyashiro EI; De la Piscina PR; Villalba LH; Notari PA; de Jesús Martínez-Pérez T; Fernández H; Gilabert P; Rosas CM; Nos P; Gil JL; Navas López VM; Muñoz F; Palomares MTD; Lucio AS; Merino O; de Prado IN; Leal C; de Carpi JM; Sánchez LB; Arce NM; Frago S; Mateu BB; Domènech E; Garcia Planella E.

    Ileal Predominance in Crohn's Disease Is Associated With Increased Intestinal Surgery and Biological Therapy Use, With Lower Treatment Persistence.

    AMERICAN JOURNAL OF GASTROENTEROLOGY. 2025; 120(1): 194-203 Nº de citas: 2 [doi:10.14309/ajg.0000000000003207]

  • Magaz M; Giudicelli-Lett H; Abraldes JG; Nicoara-Farcau O; Turon F; Rajoriya N; Goel A; Raymenants K; Hillaire S; Téllez L; Elkrief L; Procopet B; Orts L; Nery F; Shukla A; Larrue H; Degroote H; Aguilera V; Llop E; Turco L; Indulti F; Gioia S; Tosetti G; Bitto N; Becchetti C; Alvarado E; Roig C; Diaz R; Praktiknjo M; Konicek AL; Olivas P; Fortea JI; Masnou H; Puente Á; Ardèvol A; Navascués CA; Romero-Gutiérrez M; Scheiner B; Semmler G; Mandorfer M; Damião F; Baiges A; Ojeda A; Simón-Talero M; González-Alayón C; Díaz A; García-Criado Á; De Gottardi A; Hernández-Guerra M; Genescà J; Drilhon N; Noronha Ferreira C; Reiberger T; Rodríguez M; Morillas RM; Crespo J; Trebicka J; Bañares R; Villanueva C; Berzigotti A; Primignani M; La Mura V; Riggio O; Schepis F; Verhelst X; Calleja JL; Bureau C; Albillos A; Nevens F; Hernández-Gea V; Tripathi D; Rautou PE; García-Pagán JC.

    Porto-sinusoidal vascular liver disorder with portal hypertension: Natural history and long-term outcome.

    JOURNAL OF HEPATOLOGY. 2025; 82(1): 72-83 [doi:10.1016/j.jhep.2024.07.035]

  • Diaz-Ruiz, R; Poca, M; Roman, E; Panadero-Gomez, R; Cuyàs, B; Bañares, I; Morales, A; Puerto, M; Lopez-Esteban, R; Blazquez, E; Fernández-Castillo, M; Correa-Rocha, R; Rapado-Castro, M; Breton, I; Bañares, R; Soriano, G; Garcia-Martinez, R.

    Vitamin D Supplementation Is Associated with Inflammation Amelioration and Cognitive Improvement in Decompensated Patients with Cirrhosis

    Nutrients. 2025; 17(2): Nº de citas: 1 [doi:10.3390/nu17020226]

  • Albillos, A; Bañares, R; Hernández-Gea, V.

    Portal hypertension: recommendations for diagnosis and treatment. Consensus document sponsored by the Spanish Association for the Study of the Liver (AEEH) and the Biomedical Research Network Centre for Liver and Digestive Diseases (CIBERehd)

    Gastroenterologia y Hepatologia. 2025; 48(1): [doi:10.1016/j.gastrohep.2024.502208]

  • Olivera, PA; Martinez-Lozano, H; Leibovitzh, H; Xue, MY; Neustaeter, A; Espin-Garcia, O; Xu, W; Madsen, KL; Guttman, DS; Bernstein, CN; Yerushalmi, B; Hyams, JS; Abreu, MT; Marshall, JK; Wrobel, I; Mack, DR; Jacobson, K; Bitton, A; Aumais, G; Panacionne, R; Dieleman, LA; Silverberg, MS; Steinhart, AH; Moayyedi, P; Turner, D; Griffiths, AM; Turpin, W; Lee, SH; Croitoru, K.

    Healthy First-Degree Relatives From Multiplex Families vs Simplex Families Have Higher Subclinical Intestinal Inflammation, a Distinct Fecal Microbial Signature, and Harbor a Higher Risk of Developing Crohn's Disease

    GASTROENTEROLOGY. 2025; 168(1): Nº de citas: 6 [doi:10.1053/j.gastro.2024.08.031]

  • Lamas-Paz, A; Hionides-Gutierrez, A; Guo, FF; Jorquera, G; Moran-Blanco, L; Benede-Ubieto, R; Mesquita, M; Estevez-Vazquez, O; Zheng, K; Mazariegos, M; Vazquez-Ogando, E; Blazquez-Lopez, E; Asensio, I; Mutlu, B; Gomez-Santos, B; Peligros, MI; Vaquero, J; Banares, R; Delgado, TC; Martinez-Chantar, ML; Martinez-Naves, E; Sanz-Garcia, C; Mohamed, MR; Tesolato, S; Iniesta, P; Gallego-Duran, R; Maya-Miles, D; Ampuero, J; Romero-Gomez, M; Martinez-Alcocer, A; Sanfeliu-Redondo, D; Fernandez-Iglesias, A; Gracia-Sancho, J; Coll, M; Graupera, I; Gines, P; Ciudin, A; Rivera-Esteban, J; Pericas, JM; Avila, MA; Frutos, MD; Martinez-Caceres, CM; Ramos-Molina, B; Aspichueta, P; Puigserver, P; Nevzorova, YA; Cubero, FJ.

    Loss of Cdkn1a protects against MASLD alone or with alcohol intake by preserving lipid homeostasis

    Jhep Reports. 2025; 7(1): Nº de citas: 1 [doi:10.1016/j.jhepr.2024.101230]